Crile Hemostatic Forceps, 5 ½”, Curved, Titanium
$65.00 Original price was: $65.00.$50.00Current price is: $50.00.
A precision titanium hemostat delivering reliable vessel control with lightweight comfort for surgeons.
Description:
The Crile Hemostatic Forceps, 5 ½”, Curved, Titanium with a curved design are essential for clamping small to medium blood vessels during surgical procedures. Made from premium titanium, they offer exceptional durability, corrosion resistance, and reduced weight compared to traditional stainless steel. The curved jaws allow better access in confined spaces, making them suitable for general, vascular, and microsurgical applications.
Key Features:
-
5 1/2″ length with curved jaws for precise vessel clamping
-
Titanium construction for strength and lightweight handling
-
Non-magnetic and corrosion-resistant
-
Fine serrations for secure grip without damaging tissue
-
Fully sterilizable and reusable
Shipping Policy
At SurgiPortal, we ensure fast, reliable, and secure shipping of surgical instruments worldwide.
Order Processing
All orders are processed within 5–8 working days, with multiple delivery options to suit your needs:
- Standard Shipping: 7–10 business days
- Express Shipping: 4–6 business days
- Priority Delivery: 2–4 business days (available in select regions)
Delivery Partners
We collaborate with trusted global carriers such as DHL, FedEx, and UPS. Additional options include registered airmail and bulk freight solutions for clinics and hospitals.
Packing Standards
Each order is carefully packed using sterile, damage-resistant materials to maintain the highest hygiene and safety standards during transit.
Order Tracking
Upon shipment, customers receive a tracking number to monitor their order in real-time.
Reliable Delivery
Our certified delivery network ensures timely arrival of your surgical supplies in excellent condition.
With SurgiPortal’s professional medical logistics, you can count on efficient delivery and superior service—every step of the way.
Reviews
There are no reviews yet.